Target intelligence / Profile preview

ZNF816-ZNF321P readthrough transcript (ZNF816-ZNF321P)

Target
ZNF816-ZNF321P
Molecular classification
Transcription factor (KRAB domain-containing; read-through product), Other (Fusion gene/protein)
01

Overview

The ZNF816-ZNF321P readthrough transcript is a naturally occurring fusion gene product created from read-through transcription between the zinc finger protein 816 gene (ZNF816) and the zinc finger protein 321 pseudogene (ZNF321P) on human chromosome 19. The resulting protein contains a KRAB domain, which is characteristic of transcriptional repressors, and retains sequence identity with the upstream ZNF816 gene product but features a distinct C-terminus contributed by the downstream pseudogene. Although detailed biological roles and molecular functions remain unclear, the protein is predicted to participate in the regulation of gene expression, similar to other zinc finger/KRAB domain proteins. There are currently no known clinical associations, drug interactions, or established roles in disease for ZNF816-ZNF321P; its medical or therapeutic relevance is unknown.

Other names
ZNF816-ZNF321ZNF816-ZNF321 proteinZNF816-ZNF321 read-through transcriptZNF816-ZNF321 readthroughZNF816-ZNF321P
02

Biological functions

Potential regulation of gene expression (predicted transcriptional regulation)Other (full function unknown)
03

Disease associations

Other (no confirmed disease association; basic research only)

Beyond the preview

Go deeper on ZNF816-ZNF321P readthrough transcript (ZNF816-ZNF321P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF816-ZNF321P readthrough transcript (ZNF816-ZNF321P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call